Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Meghan Good

Colon & Rectal Surgery Scottsdale, AZ Medical Doctor

NPI 1437445236 CMS profile 489771

13400 E Shea Blvd, Scottsdale, AZ 85259

Open in the dashboard

General payments

$17,887

47 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Meghan Good of Scottsdale, AZ is reported in the CMS Open Payments database as having received $17,887 across 47 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $245 3
2024 General $230 2
2023 General $7,611 24
2022 General $8,147 13
2021 General $1,653 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Meghan Good
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Meghan Good were reported at $245. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Meghan Good Colon & Rectal Surgery median Middle half National median
2019 $0 $443 $125–$2,179 $163
2020 $0 $167 $53–$931 $114
2021 $1,653 $207 $72–$1,272 $132
2022 $8,147 $341 $111–$1,587 $149
2023 $7,611 $322 $115–$1,420 $160
2024 $230 $328 $112–$1,354 $164
2025 $245 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intuitive Surgical, Inc. $16,508 32 payments
  2. Medtronic, Inc. $1,122 13 payments
  3. Avita Medical Americas, LLC $148 1 payment
  4. Atricure, Inc. $109 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Education $11,500 6 payments
  2. Travel and Lodging $5,222 25 payments
  3. Food and Beverage $1,148 15 payments
  4. Gift $16 1 payment
Products named General payments · program years 2021–2025
  1. DAVINCI XI $10,500 5 payments
  2. Da Vinci Surgical System Surgery $5,008 26 payments
  3. INTERSTIM $1,040 12 payments
  4. Da Vinci Surgical System Surgery $1,000 1 payment
  5. Recell $148 1 payment
  6. AtriCure cryoICE cryoSPHERE Cryoablation System $109 1 payment
  7. Signia $82 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

166

Median for Colorectal Surgery (Proctology): 106

Drug cost

$1,911

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

22.9%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine Brand 18 $743
Loperamide Loperamide Hcl Brand 20 $712
Neomycin Sulfate Generic 39 $230
Ondansetron Hcl Generic 36 $96
Metronidazole Generic 41 $78
Oxycodone Hcl Generic 12 $51

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$69,334

Medicare's payments for the services billed

Medicare patients

172

Average age 74

Services billed

435

108 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 48%
Cancer 41%
Ischemic heart disease 34%
Diabetes 31%
Depression 30%
Osteoporosis 30%
Chronic kidney disease 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

47 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record